Bulletin
Investor Alert

Revance Therapeutics Inc.

NAS: RVNC

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202924160/composite

$

26.48

Change

0.00 0.00%

Volume

Volume 27,712

Sep 23, 2020, 4:41 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202924160/composite

Today's close

$ 27.44

$ 26.48

Change

-0.96 -3.50%

Day low

Day high

$26.41

$28.04

Open
Open: 27.45

52 week low

52 week high

$11.62

$34.62

Open

Market cap

$1.81B

Average volume

559,525

P/E ratio

N/A

Rev. per Employee

$21,935

EPS

-4.22

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rvnc

MarketWatch News on RVNC

  1. Revance Therapeutics started at buy with $50 stock price target at Stifel Nicolaus

    9:21 a.m. Jan. 29, 2019

    - Tomi Kilgore

  2. Revance to receive $30 mln upfront, potential milestone payments of up to $230.5 mln as part of license deal

    9:18 a.m. Dec. 4, 2018

    - Tomi Kilgore

  3. Revance's stock halted for news until 8:35 a.m. Eastern

    9:19 a.m. Dec. 4, 2018

    - Tomi Kilgore

  4. Revance Therapeutics enters China license agreement with Shanghai Fosun Pharmaceutical

    9:18 a.m. Dec. 4, 2018

    - Tomi Kilgore

  5. Allergan’s Stock Is Headed for a Face-Lift

    8:56 p.m. March 30, 2018

    - Barron's Online

  6. Charting the Market

    12:36 a.m. Dec. 9, 2017

    - Barron's Online

  7. Fine Lines: Why Allergan’s Botox Ain’t Beat

    11:41 a.m. Dec. 6, 2017

    - Barrons Blogs

  8. Allergan stock drops 3% after rival product's positive trial results

    1:10 p.m. Dec. 5, 2017

    - Emma Court

  9. Revance stock surges 32% on positive results for wrinkle injection in late-stage trial

    10:12 a.m. Dec. 5, 2017

    - Emma Court

  10. Revance Therapeutics stock price target raised to $32 vs. $22 at SunTrust Robinson

    8:57 a.m. Jan. 6, 2017

    - Ciara Linnane

  11. Here’s why U.S. investors might squeak past Brexit worries

    8:59 a.m. June 14, 2016

    - Barbara Kollmeyer

  12. Revance shares drop after crow's-feet treatment study fails

    4:48 p.m. June 13, 2016

    - Wallace Witkowski

  13. Revance Therapeutics started at buy with $46 stock price target at SunTrust RH

    7:39 a.m. March 23, 2016

    - Tomi Kilgore

  14. Allergan soars on Valeant bid; Netflix jumps on results

    3:12 p.m. April 22, 2014

    - Sue Chang

  15. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/rvnc

Other News on RVNC

  1. Revance Therapeutics (RVNC) Investor Presentation - Slideshow

    3:18 p.m. Sept. 11, 2020

    - Seeking Alpha

  2. Revance finalizes HintMD acquisition

    2:58 a.m. July 24, 2020

    - Seeking Alpha

  3. Revance's DAXI shows positive effect in frown line studies

    9:19 a.m. June 30, 2020

    - Seeking Alpha

  4. AbbVie's (ABBV) sBLA for Botox Gets Acceptance From FDA

    11:33 a.m. June 23, 2020

    - Zacks.com

  5. Revance Therapeutics (RVNC) Investor Presentation - Slideshow

    1:39 p.m. June 11, 2020

    - Seeking Alpha

  6. Evolus up 30% but news scarce

    11:32 a.m. May 22, 2020

    - Seeking Alpha

  7. Evolus up 31% on no news

    11:32 a.m. May 22, 2020

    - Seeking Alpha

  8. Revance to acquire HintMD in all-stock deal

    8:22 a.m. May 19, 2020

    - Seeking Alpha

  9. 10-Q: REVANCE THERAPEUTICS, INC.

    5:42 p.m. May 7, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  10. FDA OKs Galderma lip filler

    9:46 a.m. May 5, 2020

    - Seeking Alpha

  11. Revance's Shares March Higher, Can It Continue?

    9:16 a.m. April 27, 2020

    - Zacks.com

  12. How Revance (RVNC) Stock Stands Out in a Strong Industry

    8:55 a.m. April 9, 2020

    - Zacks.com

  13. SocGen cuts view on AbbVie in premarket analyst action

    6:58 a.m. March 23, 2020

    - Seeking Alpha

  14. Stocks To Watch: Fading The Fear

    8:07 a.m. March 7, 2020

    - Seeking Alpha

  15. Loading more headlines...
/news/pressrelease/company/us/rvnc

Press Releases on RVNC

  1. Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    4:05 p.m. Today

    - BusinessWire - BZX

  2. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.